Alphatec Holdings ATEC
NASDAQ ATEC
$9.48 +0.19 (+2.05%)
At close: Aug 21, 2026 · 4:00 PM EDT

Alphatec Holdings (ATEC) Cash from Financing Activities (2010 - 2026)

Alphatec Holdings (ATEC) posted Cash from Financing Activities of -$1.8 million for Q1 2026, down 961.17% sequentially from $206000.0 in Q4 2025, and down 105.77% YoY from $30.8 million in Q1 2025.

Alphatec Holdings (ATEC) Cash from Financing Activities (2010 - 2026) Analysis & Trends

Alphatec Holdings has reported Cash from Financing Activities for 17 years, with the latest figure at -$1.8 million in Q1 2026.

  • Quarterly Cash from Financing Activities fell 105.77% year-over-year to -$1.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$2.5 million (down 102.75% YoY) and the FY2025 annual result came in at $30.0 million, down 46.59% from the prior year.
  • Cash from Financing Activities slipped to -$1.8 million in Q1 2026 per ATEC's latest filing, from $206000.0 in the prior quarter.
  • Over five years, Cash from Financing Activities peaked at $151.6 million in Q4 2023 and troughed at -$4.4 million in Q1 2024.
  • A 5-year average of $27.8 million and a median of $3.2 million in 2024 frame the typical range for Cash from Financing Activities.
  • The sharpest annual moves came in 2023 and 2025: Cash from Financing Activities surged 14862.59% in 2023, then tumbled 119.61% in 2025.
  • Over 5 years, Cash from Financing Activities stood at $1.0 million in 2022, then soared by 14862.59% to $151.6 million in 2023, then sank by 66.59% to $50.6 million in 2024, then tumbled by 99.59% to $206000.0 in 2025, then slumped by 961.17% to -$1.8 million in 2026.
  • According to Business Quant data, Cash from Financing Activities over the past three periods registered -$1.8 million, $206000.0, and -$1.3 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Financing Activities (Qtr)
1 Abbott Laboratories 202.72 Bn 197.12 Bn 7.27 Bn -3.52 Bn
2 Stryker 126.42 Bn 122.94 Bn 4.50 Bn -95.00 Mn
3 Medtronic 119.75 Bn 110.53 Bn 6.41 Bn -888.00 Mn
4 Boston Scientific 74.13 Bn 73.60 Bn 3.85 Bn -410.00 Mn
5 Edwards Lifesciences 51.78 Bn 47.53 Bn 1.35 Bn -300,000.00
6 Dexcom 35.29 Bn 33.34 Bn 830.00 Mn -607.30 Mn
7 GE HealthCare Technologies 33.95 Bn 31.85 Bn 2.18 Bn -236.00 Mn
8 Koninklijke Philips 26.22 Bn 22.90 Bn 4.55 Bn -1.34 Bn
9 Steris 23.21 Bn 22.73 Bn 684.20 Mn -213.50 Mn
10 Alphatec Holdings 1.48 Bn 1.36 Bn 154.10 Mn -19.53 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 -19.53 Mn
Jun 30, 2026 -19.53 Mn
Mar 31, 2026 -1.77 Mn
Mar 31, 2026 -1.77 Mn
Dec 31, 2025 206,000.00
Dec 31, 2025 206,000.00
Sep 30, 2025 -1.31 Mn
Sep 30, 2025 -1.31 Mn
Jun 30, 2025 366,000.00
Jun 30, 2025 366,000.00
Mar 31, 2025 30.76 Mn
Mar 31, 2025 30.76 Mn
Dec 31, 2024 50.64 Mn
Dec 31, 2024 50.64 Mn
Sep 30, 2024 6.69 Mn
Sep 30, 2024 6.69 Mn
Jun 30, 2024 3.24 Mn
Jun 30, 2024 3.24 Mn
Mar 31, 2024 -4.37 Mn
Mar 31, 2024 -4.37 Mn